nAMD: Poor Response -- When to Switch Therapies?

Keeping Current
30/08/2021 34 min
nAMD: Poor Response -- When to Switch Therapies?

Listen "nAMD: Poor Response -- When to Switch Therapies?"

Descargar episodio Ver en sitio original

Episode Synopsis

Experts review study data and case studies to provide insights on when best to switch therapies when treating patients with nAMD. Credit available for this activity expires: 8/27/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/957277?src=mkm_podcast_addon_957277

More episodes of the podcast Keeping Current

The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology 05/01/2026
Achieving Brain Health in Epilepsy: What Can Clinicians Do? 05/01/2026
Patient Case Challenge: How Would You Manage This Patient With MASH? 31/12/2025
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies 24/12/2025
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences 19/12/2025
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy 18/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies 12/12/2025
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies 10/12/2025
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA